C4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Growth in Short Interest

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 11,340,000 shares, an increase of 11.8% from the April 30th total of 10,140,000 shares. Based on an average daily trading volume, of 1,930,000 […]

Related Keywords

Stifel Nicolaus ,Therapeutics Company Profile ,Caxton Associates ,Vanguard Group Inc ,Wells Fargo Company ,Entrypoint Capital ,Therapeutics Inc ,Farallon Capital Management ,Nasdaq ,Morgan Stanley ,Get Free Report ,Capital Management ,Point Capital ,Vanguard Group ,